Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists

As a currently spotlighted method for cancer treatment, cancer immunotherapy has made a lot of progress in recent years. Among tremendous cancer immunotherapy boosters available nowadays, Toll-like receptor (TLR) agonists were specifically selected, because of their effective activation of innate an...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Sehwan, Choi, Yunyoung, Kim, Kyobum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466827/
https://www.ncbi.nlm.nih.gov/pubmed/34575449
http://dx.doi.org/10.3390/pharmaceutics13091374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466827/
https://www.ncbi.nlm.nih.gov/pubmed/34575449
http://dx.doi.org/10.3390/pharmaceutics13091374

Ejemplares similares